NCT05490628

Brief Summary

One of the most common complications in stroke patients is cognitive impairment. Cognitive impairment affects a large part of the life of stroke patients. However, the relationship between cognitive impairment and fear of falling in stroke patients has not been investigated in any study yet. Various treatment approaches have been developed to improve cognitive function. While some of these approaches focus on improving cognitive function, others aim to reach the maximum functional level with various compensation methods taught to the patient in the current cognitive situation. As a result of cognitive interventions, stroke patients' participation in daily life, adherence to treatment and quality of life increase. The aim of this study is to investigate the effects of cognitive interventions on motor performance, balance and fear of falling. This study will contribute to the literature by investigating these effects of cognitive rehabilitation.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable stroke

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 6, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 5, 2022

Completed
27 days until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

August 5, 2022

Status Verified

August 1, 2022

Enrollment Period

1 month

First QC Date

July 6, 2022

Last Update Submit

August 4, 2022

Conditions

Outcome Measures

Primary Outcomes (8)

  • Montreal Cognitive Assessment

    Developed to evaluate mild cognitive impairments, Montreal Cognitive Assessment assesses different cognitive abilities including executive functions, visuospatial skills, memory, language, attention concentration, abstract thinking, calculation and orientation. It takes about 10 minutes to administer and the highest total score that can be obtained from the test is 30. Accordingly, scores of 21 and above are considered normal.

    a day before the study start

  • Montreal Cognitive Assessment

    Developed to evaluate mild cognitive impairments, Montreal Cognitive Assessment assesses different cognitive abilities including executive functions, visuospatial skills, memory, language, attention concentration, abstract thinking, calculation and orientation. It takes about 10 minutes to administer and the highest total score that can be obtained from the test is 30. Accordingly, scores of 21 and above are considered normal.

    through study completion, an average of 2 months

  • Fugl-Meyer Assessment

    The Fugl-Meyer Assessment is used to evaluate any loss or abnormality in physiological, anatomical structure or function in motor function.

    a day before the study start

  • Fugl-Meyer Assessment

    The Fugl-Meyer Assessment is used to evaluate any loss or abnormality in physiological, anatomical structure or function in motor function.

    through study completion, an average of 2 months

  • Tinetti Balance & Gait Test

    Tinetti Balance and Gait Scale is used to evaluate patients' balance and gait.

    a day before the study start

  • Tinetti Balance & Gait Test

    Tinetti Balance and Gait Scale is used to evaluate patients' balance and gait.

    through study completion, an average of 2 months

  • Falls Efficacy Scale International (FES-I)

    FES-I is a self-report questionnaire that provides information on the level of anxiety about falls for 16 activities of daily living.

    a day before the study start

  • Falls Efficacy Scale International (FES-I)

    FES-I is a self-report questionnaire that provides information on the level of anxiety about falls for 16 activities of daily living.

    through study completion, an average of 2 months

Secondary Outcomes (4)

  • The Timed Up & Go (TUG) Test

    a day before the study start

  • The Timed Up & Go (TUG) Test

    through study completion, an average of 2 months

  • 10 meter walking test

    a day before the study start

  • 10 meter walking test

    through study completion, an average of 2 months

Study Arms (2)

Control Group

ACTIVE COMPARATOR

Traditional exercises: stretching exercises, strengthening exercises, balance exercises, walking exercises and fine motor skill exercises.

Other: Conventional Therapy

Cognitive Rehabilitation Group

EXPERIMENTAL

Cognitive rehabilitation; memory, executive function, attention, concentration and calculation exercises.

Other: Cognitive RehabilitationOther: Conventional Therapy

Interventions

Language, memory, attention and executive function exercises are performed for the participants' deficient cognitive functions.

Cognitive Rehabilitation Group

Strengthening, walking, balance and coordination exercises are performed according to the needs of the participants.

Cognitive Rehabilitation GroupControl Group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Having been diagnosed with stroke
  • The duration of the disease is in the range of 1-24 months
  • Having a score of 21 or lower on the mini mental state test
  • Having received 3 or more according to the Functional Ambulation Scale
  • Not having a vision problem that will affect the vision of the materials to be used during the treatment
  • Being able to communicate sufficiently to understand the simple orders given

You may not qualify if:

  • Having been diagnosed with bilateral stroke
  • Having a neurological disease other than the diagnosis of stroke
  • Development of aphasia after stroke

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Hoffmann T, Bennett S, Koh CL, McKenna KT. Occupational therapy for cognitive impairment in stroke patients. Cochrane Database Syst Rev. 2010 Sep 8;2010(9):CD006430. doi: 10.1002/14651858.CD006430.pub2.

    PMID: 20824849BACKGROUND
  • Miller EL, Murray L, Richards L, Zorowitz RD, Bakas T, Clark P, Billinger SA; American Heart Association Council on Cardiovascular Nursing and the Stroke Council. Comprehensive overview of nursing and interdisciplinary rehabilitation care of the stroke patient: a scientific statement from the American Heart Association. Stroke. 2010 Oct;41(10):2402-48. doi: 10.1161/STR.0b013e3181e7512b. Epub 2010 Sep 2. No abstract available.

    PMID: 20813995BACKGROUND
  • Niemeijer M, Svaerke KW, Christensen HK. The Effects of Computer Based Cognitive Rehabilitation in Stroke Patients with Working Memory Impairment: A Systematic Review. J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105265. doi: 10.1016/j.jstrokecerebrovasdis.2020.105265. Epub 2020 Sep 11.

    PMID: 32992171BACKGROUND
  • Liu TW, Ng GYF, Chung RCK, Ng SSM. Cognitive behavioural therapy for fear of falling and balance among older people: a systematic review and meta-analysis. Age Ageing. 2018 Jul 1;47(4):520-527. doi: 10.1093/ageing/afy010.

    PMID: 29471428BACKGROUND

MeSH Terms

Conditions

StrokeCognition Disorders

Interventions

Cognitive Training

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Neurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Rüstem Mustafaoğlu

    IstanbulUniversity-Cerrahpasa

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly divided into intervention and control groups. Both groups will be treated for 6 weeks. Each participant will be treated for a total of thirty hours, one hour a day, five days a week.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 6, 2022

First Posted

August 5, 2022

Study Start

September 1, 2022

Primary Completion

October 1, 2022

Study Completion

December 1, 2022

Last Updated

August 5, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share